Daily Stock Analysis, SLV, SIMULATIONS PLUS INC, priceseries

SIMULATIONS PLUS INC. Daily Stock Analysis
Stock Information
Open
23.54
Close
23.70
High
23.77
Low
23.43
Previous Close
23.64
Daily Price Gain
0.06
YTD High
23.79
YTD High Date
Mar 4, 2022
YTD Low
20.34
YTD Low Date
Feb 3, 2022
YTD Price Change
2.52
YTD Gain
11.90%
52 Week High
26.39
52 Week High Date
Jun 1, 2021
52 Week Low
19.80
52 Week Low Date
Dec 15, 2021
52 Week Price Change
0.42
52 Week Gain
1.80%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jul 15. 2019
14.32
Jul 31. 2019
15.15
12 Trading Days
5.78%
Link
LONG
May 7. 2020
14.16
Jun 5. 2020
16.06
20 Trading Days
13.39%
Link
LONG
Jul 7. 2020
16.95
Aug 11. 2020
23.70
25 Trading Days
39.84%
Link
LONG
Dec 15. 2020
22.76
Jan 8. 2021
24.55
16 Trading Days
7.84%
Link
Company Information
Stock Symbol
SLV
Exchange
NASDAQ
Company URL
http://www.simulations-plus.com
Company Phone
661-723-7723
CEO
Walter S. Woltosz
Headquarters
California
Business Address
42505 10TH STREET WEST, LANCASTER, CA 93534-7059
Sector
Equity
Industry Category
Computer Software & Services
Industry Group
Business Software & Services
CIK
0001023459
About

Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. Its services include consulting services, modeling and analysis or simulation, pharcometric data assembly, and training and workshops. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.

Description

Simulations Plus, Inc. develops and sells drug discovery and development software for mechanistic modeling and simulation. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a standalone program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for NCA and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program, which takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher that integrates with MedChem Studio and ADMET Predictor. In addition, it offers MedChem Studio, a software tool for data mining and designing new molecules; and KIWI, a cloud-based Web application, which organizes, processes, maintains, and communicates the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program. Further, the company provides consulting services ranging from early drug discovery through preclinical and clinical trial data analysis, and for submissions to regulatory agencies; and population modeling and simulation contract research services for the pharmaceutical and biotechnology industries. Additionally, it offers pharmaceutical/chemistry software to pharmaceutical, biotechnology, agrochemical, and food companies. The company distributes its products and services worldwide. Simulations Plus, Inc. was founded in 1996 and is headquartered in Lancaster, California.